BETA - Beta Drugs | Wealthrox

← Go Back

Beta Drugs

BETA · Pharma > Pharmaceuticals & Drugs · Chairman: Rahul Batra · MD: Rahul Batra · Listing date: Oct. 13, 2017

Stock Price vs Company Growth

0.7%

3.0%

9.9%

42.3%

91.0%

12.3%

46.0%

all

41.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 2,140 0.7%

1,460

2,808

Company Overview

Sales

407 Cr

Growth: 5.5%

Profit after Tax

45.1 Cr

Growth: 17.7%

Small Cap

2,380 Cr

P/E: 49.0x

Industry P/E: 34.2x

Fundamentals

Sales (Cr)	₹ 407
Growth	5.5%
EBITDA	20.1%
P/S	5.8x
Dividend	0.0%
P/E	49.0x
Book Value	₹ 219
PEG Ratio	9.3x
ROE	20.1%
P/B	10.1x

Shareholding Pattern

Institutions

Suryavanshi Commotrade Private Limited

6.71 %

Ashish Kacholia

4.93 %

Bsas Infotech Ltd

1.27 %

Ankush Kedia

1.12 %

Onkar Singh

1.05 %

Promoters

Vijay Kumar Batra

65.69 %

Rahul Batra

0.36 %

Varun Batra

0.35 %

Neeraj Batra

0.28 %

Heena Batra

0.01 %

Others

Increase Decrease No change

Company Profile Detailed

Beta Drugs is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.

Investors (7)

onkar.si...

airavat....

bsas.inf...

Followers (1)

random